Mersana Therapeutics, Inc. Stock Split Ratio
Mersana Therapeutics, Inc. had Stock Split Ratio of 4.00% as of 2025-07-25, per its 10-Q filed 2025-11-14.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:StockholdersEquityNoteStockSplitConversionRatio1 · last filed 2025-11-14
- 2025-07-25: Stockholders' Equity Note, Stock Split, Conversion Ratio 4.00%.
- 2017-06-15: Stockholders' Equity Note, Stock Split, Conversion Ratio 22.22%.
| Period end | Stockholders' Equity Note, Stock Split, Conversion Ratio |
|---|---|
| 2025-07-25 | 4.00% 10-Q · filed 2025-11-14 |
| 2017-06-15 | 22.22% 10-Q · filed 2018-11-13 |